Potent, selective, and orally active prostaglandin D2 receptor antagonist

Novel potent inhibitor of protein-protein interactions

Metabolite of Cilostazol

Antioxidant and free radical scavenger, attenuating edema formation, and subsequent tissue damage following cortical contusion

Inhibitor of calmodulin action in calcium regulation

Novel negative allosteric modulator (NAM) of mGlu4, being isomerized with blue-light/dark cycles with fast relaxation

Novel Potent, Well Tolerated, and Orally Active Protective Agent against Aminoglycoside-Induced Hearing Loss

Collagen immunostain

Novel mixed κ/μ receptor antagonist. having therapeutic potential for the treatment of depression and other stress-induced conditions

Negative allosteric modulator at the CB1 receptor

CB1 allosteric modulator

Selective p38alpha and p38beta kinase inhibitor

Lipoglycopeptide Antibacterial, acting as a inhibitor of Cytochrome P450 2C19/2C9, and a inducer of Cytochrome P450 3A4/2D6

Novel sodium/calcium exchanger (NCX) inhibitor

Novel potent dual orexin 1/2 receptor (OX1/2R) antagonist for the treatment of insomnia

Inhibitor of an enzyme responsible for the multidrug resistance phenotype in the yeast Saccharomyces cerevisiae.

Peripheral weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist, preventing from being absorbed and entering the central nervous system

Second-generation taxane derivative with potential antineoplastic activity, binding to and stabilizing tubulin molecules, inhibiting cell division and cellular proliferation

Inhibitor of the influenza neuramidase enzyme, blocking neuraminidases on the surfaces of influenza viruses, interfering with host cell release of complete viral particles

Novel potent, orally efficacious, dual inhibitor of cMET and RON kinases

Novel cGMP phosphodiesterase (cGMP-PDE) inhibitor

Inhibitor of the glycan-processing enzyme endoplasmic-reticular glucosidase